Jaguar Health stock gains after special dividend decision

Published on 10/06/2026 at 10:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Jaguar Health stock gained 29.23 percent on October 5 as a preferred-share dividend set October 13 eligibility. Each Series R share converts into five common shares on November 2.

JAGX, US47010C8543, Illustration mit AI erstellt.

Jaguar Health (ISIN US47010C8543) was last at USD 4.73 on Nasdaq on October 5, 2026 at 4:00 p.m. ET, up 29.23 percent from USD 3.66. The move followed a special preferred-stock dividend announced on October 2, 2026, according to Jaguar Health.

Dividend sets three key dates

Eligible common shareholders and certain warrant holders of record on October 13, 2026 are due one Series R Convertible Preferred share for each qualifying common share. The payment date is October 15, 2026, according to Jaguar Health.

The preferred shares are scheduled to convert into five common shares each on November 2, 2026. The filing also sets a 19.99 percent beneficial-ownership limit and caps aggregate conversion shares at 11.625 million, according to StockTitan.

Conversion terms carry dilution risk

The structure gives eligible holders a preferred security first, but the scheduled conversion also creates a clear supply risk for common shareholders. The filing says the additional shares may depress the common-stock price and make future equity financing more difficult, according to StockTitan.

Sell consensus contrasts with price move

MarketBeat lists a Sell consensus for Jaguar Health based on one research report, placing the recent price reaction against a cautious analyst backdrop. The same page identifies biotechnology as the company industry and records one analyst report in the past 90 days, according to MarketBeat.

JAGX remains a micro-cap stock

Jaguar Health had a market capitalization of USD 2.1 million and trading volume of 15,733,255 shares on October 5, 2026. Its 52-week range was USD 2.35 to USD 1,267.88, while the USD 4.73 price remained USD 1.07 above the prior close.